Fisher David 4

What Happened

• David Fisher, Executive Chairman and Director of Enova International (ENVA), exercised derivative awards and immediately sold the resulting 37,989 shares. He paid about $23.96 per share to exercise (total cost ~$910,216) and sold the shares in the open market at a weighted-average price of $165.31 per share for gross proceeds of approximately $6,280,152. The related underlying option was marked as disposed/expired as part of the tandem exercise.

Key Details

• Transaction date: January 30, 2026.
• Exercise/acquisition: 37,989 shares at $23.96 each — total exercise cost ~$910,216.
• Sale: 37,989 shares at a weighted-average price of $165.31 — gross proceeds ~$6,280,152. (Sale executed in multiple trades at prices ranging $163.885–$166.73; weighted avg reported.)
• Derivative disposition: 37,989 shares shown as disposed at $0.00 reflecting expiration of the related option upon exercise of the SAR/option.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Filing timeliness: Form 4 filed Feb 3, 2026 for a Jan 30, 2026 transaction (filed within the SEC’s standard 2 business-day window).
• Notable footnotes: The transaction involved a limited stock appreciation right (SAR) and employee stock option granted in tandem (exercise of one cancels the other). The SAR payout is tied to an "Offer Value Per Share" and is payable only if an “Offer” (as defined in the grant) occurs. Options vested in roughly one-third increments on Feb 12, 2020, 2021, and 2022.

Context

• This was effectively a cashless exercise: Fisher exercised rights (incurring the exercise cost) and sold all shares the same day. For retail investors, purchases can signal insider confidence; sales like this are common for liquidity or tax purposes and don’t by themselves indicate a change in company fundamentals. The filing is informational and was submitted on time.